Metaceutic ApS: Financial statements 2024
CVR: 40638350
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Metaceutic ApS (CVR 40638350) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -48,469 and a net result of DKK -1,318,986 compared with DKK -2,036,587 the year before. Equity in the 2024 report amounted to DKK -2,087,785. The company had 1 employee in the financial year.
- Gross Profit
- DKK -48,469
- Profit/Loss
- DKK -1,318,986
- Equity
- DKK -2,087,785
- Total Assets
- DKK 953,804
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -48 t. | -1.3 mio. | -2.1 mio. | 1 |
| 2023 | - | -1.2 mio. | -2 mio. | -769 t. | 1 |
| 2022 | - | -987 t. | -1.8 mio. | 1.3 mio. | 2 |
| 2021 | - | -2.2 mio. | -4.2 mio. | 2.1 mio. | 4 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Metaceutic ApS has published its annual report for 2023. Gross profit came to DKK -1,182,542, and the net result was DKK -2,036,587.
As of June 19, 2024, Jan Greve has left the board of directors of Metaceutic ApS.
As of June 19, 2024, Kim Erik Ginnerup has left the board of directors of Metaceutic ApS.
As of June 19, 2024, Ali Kazemi Seresht has left the board of directors of Metaceutic ApS.
About Metaceutic ApS
Metaceutic ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ali Kazemi Seresht. The company is owned by Ginnerup Capital ApS and A. Kazemi ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,095,622 and a net result of DKK 2,364,576 compared with DKK -1,318,986 the year before. Equity in the 2025 report amounted to DKK 276,791.